Ncm Usa Bronx Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NCM USA BRONX LLC
NCM USA BRONX LLC has three approved drugs.
Drugs and US Patents for Ncm Usa Bronx Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ncm Usa Bronx Llc | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 204512-001 | Jan 7, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ncm Usa Bronx Llc | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 204515-001 | Feb 4, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ncm Usa Bronx Llc | SODIUM FLUORIDE F-18 | sodium fluoride f-18 | INJECTABLE;INTRAVENOUS | 204513-001 | Nov 28, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

